ABBV241115P265000
- 0.00
- 0.000.00%
AbbVie Newsroom
Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
AbbVie's (NYSE:ABBV) Shareholders Will Receive A Bigger Dividend Than Last Year
Large Pension Doubled Palantir Stake, Bought Up Intel and CVS Stock
Trending Stocks This Week as Wall Street Sells off Amid Fed Remarks
Why AbbVie's (ABBV) Drug Setback Creates A Prime Buy-The-Dip Moment
Dividend King AbbVie Just Paid Investors: Here's How Much They Got
Weekly Buzz: Not All Parties Last Forever
Market Falls to End All-Time High Week | Wall Street Today
U.S. Pharma Is Largely Immune From 'MAHA' Impact: Wolfe
Redburn Atlantic Adjusts AbbVie's Price Target to $216 From $215, Keeps Buy Rating
AbbVie on Track for Longest Losing Streak Since September 2016 -- Data Talk
Market Falls Friday After Light Earnings and 13F's | Live Stock
AbbVie, Bitcoin And An Energy Stock On CNBC's 'Final Trades'
Is AbbVie (NYSE:ABBV) Using Too Much Debt?
Got $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its Stock
US MOVERS&SHAKERS Nov 11-Nov 15, 2024
Viking Fund Management Sells Big Oil Stocks In Q3, Cuts Tesla Position In Half, Adds To Largest Position Broadcom
Market Falls Thursday, Powell Said Fed Will Take Things Slow | Wall Street Today
Wolfe Research Initiates AbbVie(ABBV.US) With Buy Rating, Announces Target Price $205
AbbVie Options Spot-On: On November 14th, 141.69K Contracts Were Traded, With 422.71K Open Interest